RxDoctor Payments Data

Christen Shea

Family · Covington, LANPI 1982221438

Payments from drug & device makers

$364in general payments, 2019–2025

Across 21 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$50
  • Johnson & Johnson$46
  • GSK$32
  • Exact Sciences$25
  • Abbott$25
  • AbbVie$24
  • plus $163 from 10 others

What the payments were for

  • Food & beverage$364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$364 in reported general payments places this provider in the 40th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,163
Medicare patients
183
Services billed
248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$61,017
MounjaroTirzepatide24$35,283
JardianceEmpagliflozin21$33,165
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,255
EliquisApixaban12$15,630
TrulicityDulaglutide12$12,344
LinzessLinaclotide16$12,330
SynthroidLevothyroxine Sodium30$3,806
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,214
Levothyroxine Sodium253$1,988
Albuterol Sulfate HfaAlbuterol Sulfate71$1,723
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,305
Pantoprazole Sodium163$1,124
Rosuvastatin Calcium144$1,119
Losartan Potassium86$880

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$61,01755 claims
Lilly USA, LLCMounjaro, Trulicity$15$47,62736 claims
GSKTrelegy Ellipta$32$20,25530 claims
AbbVieLinzess, Synthroid$24$16,13646 claims
PfizerEliquis$50$15,63012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,610 family providers in Louisiana.

Other family in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →